Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Mar 11, 2026
Why Is AeroVironment (AVAV) Stock Down -10% Today?

Why Is AeroVironment (AVAV) Stock Down -10% Today?

Key Takeaways

  • AVAV shares dropped approximately 10% in premarket trading on March 11, 2026, following a disappointing Q3 fiscal 2026 earnings report released after the prior session's close
  • Q3 revenue of $408.0 million came in far below analyst consensus of approximately $475–$488 million, representing a massive top-line miss
  • Adjusted EPS of $0.64 missed the consensus estimate of approximately $0.71–$0.72
  • Management slashed full-year FY2026 guidance, cutting adjusted EPS expectations to $2.75–$3.10 from the prior range of $3.40–$3.55, and trimming revenue guidance to $1.85–$1.95 billion
  • A $151.3 million non-cash goodwill impairment charge — triggered by the U.S. Space Force stop-work order on the SCAR program — drove a GAAP net loss of $156.6 million, or $3.15 per diluted share
  • Traders are closely watching whether Q4 can deliver the "record revenue" management promised, as well as any developments in the Space Force SCAR program recompetition

Opening Summary

AeroVironment, Inc. (AVAV) is a Nasdaq-listed aerospace and defense company specializing in unmanned aircraft systems (UAS), loitering munitions, and tactical missile systems, with growing exposure to space communications infrastructure. Shares fell approximately 10% in Wednesday's premarket session, with the stock trading near the $204–$205 range against the prior session's closing price of $227.29. The sharp decline followed the company's after-hours release of third-quarter fiscal 2026 results, which badly missed Wall Street expectations on both revenue and earnings while simultaneously delivering a dramatic guidance cut.

Q3 Earnings Miss: The Core Catalyst

AVAV reported Q3 fiscal 2026 adjusted EPS of $0.64, falling short of the consensus estimate of approximately $0.71–$0.72 per share. Revenue of $408.0 million came in roughly $67–80 million below analyst expectations in the range of $475–$488 million — a miss of more than 15%. While revenue still surged 143% year-over-year due to the BlueHalo acquisition, the shortfall relative to expectations shocked investors who had anticipated a stronger execution quarter.

SCAR Stop-Work Order and Goodwill Impairment

The single most damaging development in the quarter was the financial fallout from the U.S. Space Force's stop-work order on AeroVironment's BADGER phased array antenna systems for the Satellite Communication Augmentation Resource (SCAR) program. Issued in January 2026, the stop-work order triggered a mandatory goodwill impairment test for the company's Space reporting unit, resulting in a non-cash charge of $151.3 million. The impairment also wiped approximately $1.49 billion from the company's unfunded backlog, materially altering the long-term revenue outlook for the Space segment. GAAP net loss for the quarter ballooned to $156.6 million, or $3.15 per diluted share, versus a loss of just $1.8 million a year earlier.

Guidance Cut Amplifies Investor Concern

Beyond the headline miss, management's decision to slash full-year FY2026 guidance delivered a second blow to investor confidence. AeroVironment now expects adjusted EPS in the range of $2.75–$3.10, down sharply from the prior guidance of $3.40–$3.55 and well below the analyst consensus of approximately $3.31. Revenue guidance was trimmed to $1.85–$1.95 billion, versus the FactSet estimate of $1.96 billion. CEO Wahid Nawabi cited "revenue timing and adjustments" in the Space business as the primary driver and expressed confidence in record Q4 revenue, but the magnitude of the downward revision overshadowed any optimism.

Analyst Downgrades Add Pressure

The earnings-driven sell-off is compounded by a deteriorating analyst sentiment backdrop. Raymond James issued a dramatic double downgrade on AVAV on March 2, moving from Strong Buy all the way to Underperform — skipping the Hold rating entirely — citing the SCAR program recompetition as a threat to the company's largest program of record, valued at approximately $1.4 billion. RBC Capital's Ken Herbert maintained an Outperform rating but cut his price target from $375 to $325 in early March. Robert W. Baird similarly reduced its target from $350 to $260, though it maintained an Outperform rating. Pomerantz LLP has also launched an investigation into potential securities fraud claims related to investor losses, adding legal overhang to the stock.

Market Context and Trading Activity

AVAV shares have been in a prolonged downtrend, now trading approximately 61% below their 52-week high of $417.86. Prior to Tuesday's earnings release, the stock closed at $227.29 — already a historically depressed level compared to January peaks above $390. The premarket decline of approximately 10% on heavy volume reflects the compounding effect of the earnings miss, guidance reduction, and ongoing SCAR program uncertainty. The broader defense sector, tracked via ETFs such as ITA, has not exhibited sympathy selling of comparable magnitude, indicating that the pressure on AVAV is stock-specific rather than sector-wide.

Trending AI Robots

For traders navigating volatile defense and aerospace names like AVAV, Tickeron's Trending AI Robots page offers a curated list of the platform's top-performing AI trading bots under current market conditions. Tickeron operates hundreds of AI bots covering thousands of tickers, but only those demonstrating the strongest recent performance metrics are featured in this Trending section. Bots vary widely by strategy, time horizon, risk profile, and traded symbols — ranging from short-term momentum plays to longer swing-trading approaches. Investors and active traders looking to incorporate algorithmic signals into their decision-making can explore the full range of available bots and performance data on Tickeron's platform.

What Comes Next for AVAV

The most critical near-term catalyst for AVAV is the company's Q4 fiscal 2026 earnings report, with management having explicitly guided for record revenue in that period — a claim the market will be watching closely. Any updates on the Space Force's SCAR program recompetition process will be pivotal: if AeroVironment fails to win back the contract or secure comparable business, the Space segment write-down may prove to be the beginning rather than the end of program-related headwinds. The Pomerantz securities investigation adds a layer of legal uncertainty that could weigh on sentiment independent of operational results. On the positive side, management highlighted robust order flow, growing funded backlog, and strong demand for loitering munitions and drone systems — underlying business fundamentals that could help the stock stabilize if execution improves.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: AVAV

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


Momentum Indicator for AVAV turns positive, indicating new upward trend

AVAV saw its Momentum Indicator move above the 0 level on September 14, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned positive. In 72 of the 86 cases, the stock moved higher in the following days. The odds of a move higher are at 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for AVAV just turned positive on September 14, 2026. Looking at past instances where AVAV's MACD turned positive, the stock continued to rise in 40 of 50 cases over the following month. The odds of a continued upward trend are 80%.

AVAV moved above its 50-day moving average on September 17, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +7.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where AVAV advanced for three days, in 246 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

Bearish Trend Analysis

The 10-day RSI Indicator for AVAV moved out of overbought territory on August 13, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In 28 of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at 78%.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The 10-day moving average for AVAV crossed bearishly below the 50-day moving average on August 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 60%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVAV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.

AVAV broke above its upper Bollinger Band on September 17, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for AVAV entered a downward trend on September 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 74 (best 1 - 100 worst), indicating slightly worse than average price growth. AVAV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.849) is normal, around the industry mean (6.438). P/E Ratio (149.026) is within average values for comparable stocks, (59.605). Projected Growth (PEG Ratio) (1.565) is also within normal values, averaging (2.578). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (3.893) is also within normal values, averaging (18.155).

The Tickeron Profit vs. Risk Rating rating for this company is 83 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVAV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 40.8B. The market cap for tickers in the group ranges from 4.49 to 2.01T. SPCX holds the highest valuation in this group at 2.01T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -1%. For the same Industry, the average monthly price growth was -14%, and the average quarterly price growth was -7%. ELMT experienced the highest price growth at 42%, while VWAV experienced the biggest fall at -44%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 199%. For the same stocks of the Industry, the average monthly volume growth was 173% and the average quarterly volume growth was 25%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 69
Price Growth Rating: 66
SMR Rating: 77
Profit Risk Rating: 74
Seasonality Score: 7 (-100 ... +100)
View a ticker or compare two or three
AVAV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of unmanned aircraft and charging systems

Industry AerospaceDefense

Profile
Details
Industry
Aerospace And Defense
Address
241 18th Street South
Phone
+1 703 418-2828
Employees
4091
Web
https://www.avinc.com
Interact to see
Advertisement
Micron Technology’s common stock MU (MU) rose 5.13% in the latest completed session, closing at 426.13 dollars versus 405.35 dollars previously. The move appears driven by continued enthusiasm around Micron’s role as a key memory supplier to artificial intelligence and data center markets, supporting an earnings-driven re‑rating of the stock.
IperionX Limited (IPX) is down about 15.57% in early trading on March 16, with shares recently changing hands near 29.44 dollars versus a previous close of 34.87 dollars. The drop extends a post‑earnings selloff after the company’s March 12 results highlighted continued losses and substantial funding needs to scale its titanium operations.
Shares of CTMX surged roughly 56% in the latest session, staging a sharp intraday price rally from the prior close. The move appears driven by earnings-related positioning and growing optimism around CytomX’s PROBODY therapeutic platform and late‑stage oncology pipeline.
Hyperliquid Strategies Inc (PURR) shares jumped about 15% in the latest session, extending a multi-week price rally tied to digital-asset exposure. The move comes as traders bid up proxy plays on the Hyperliquid ecosystem and HYPE token, with renewed risk appetite in crypto-related assets.
VIA fell over 11% today, extending a slide that began last week; the stock has been under pressure since trading around the high‑teens and low‑$20s, well below its $46 IPO price.
LAES fell more than 19% today as the market digested a $125 million registered direct offering of 30.4 million new shares (or pre‑funded warrants) plus warrants for up to 60.8 million additional shares, all priced at $4.11 per unit.
Shares of ALDX are down about 73.02% in premarket trading, plunging from a prior close near 4.13 dollars to roughly 1.11 dollars after a major regulatory setback. The collapse follows fresh confirmation that the U.S. Food and Drug Administration has again declined to approve reproxalap for dry eye disease, issuing another Complete Response Letter that questions efficacy.
Shares of MVST are down about 25% in premarket trading today compared with the prior close. The slide follows a sharp reassessment of the company’s outlook as investors react to new information and recent volatility in high‑beta battery and EV names.
Solaris Energy Infrastructure’s stock SEI jumped roughly 13% in today’s session, extending a sharp recent rebound from early-March lows. The move is driven by ongoing post-earnings momentum after strong Q4 and full‑year 2025 results and raised guidance highlighted rapid growth in its power solutions business.
Shares of LMND are trading approximately +10% higher intraday on Tuesday, March 17, 2026, rising from a prior close of $57.74 to around $63.51. Primary catalyst: Morgan Stanley upgraded LMND to an 'Overweight' rating and raised its price target to $85 from $80.
Shares of ICHR surged approximately +15% intraday on Tuesday, March 17, 2026, trading near $48.98 versus a prior closing price of $42.59. The primary catalyst is a high-profile analyst upgrade by Stifel, with analyst Brian Chin upgrading the stock to Buy citing improved cyclical strength and conviction in the company's revenue and margin trajectory.
NBIS shares are down approximately 10.00% in Tuesday's session, falling from a prior close of $129.85 to around $116.87. The primary catalyst is Nebius Group's pre-market announcement of a proposed $3.75 billion convertible senior notes offering, sparking dilution concerns.
TME shares fell over 20% today, with the stock sliding from the mid‑$15s toward the low‑$13s in the wake of its Q4 2025 report and earnings call, extending a pre‑market drop of roughly 12–13%.
HUYA shares fell over 11% today, dropping from the mid‑$3 range toward the low‑$3s following the company’s Q4 2025 earnings release before the U.S. market open. Q4 total net revenues rose about 16% year over year to roughly CNY 1.74 billion, with full‑year 2025 revenues up around 7% to CNY 6.5 billion, but the market had already priced in a rebound after a difficult 2024.​
CWCO fell over 9% today, trading around the low‑$31 range versus recent levels in the mid‑$30s to near $39, as the market reacted negatively to Q4 2025 results and forward commentary. Full‑year 2025 results showed stable earnings and dividend growth but a roughly 9% decline in services revenue to about $46.3 million, reflecting a slowdown in project‑based construction work.
SMTC shares dropped over 8% today after the company reported Q4 results that met or modestly beat Street estimates but showed the slowest year‑over‑year revenue growth in several quarters, at about 9.3% to roughly $274–275 million.
AXTI shares slipped more than 6% today, reversing part of a powerful rally that had recently driven the stock to a 52‑week high above $47 and more than doubled its price year‑to‑date. Q4 2025 revenue of about $23.0 million missed consensus by roughly $1.2 million and fell 8–18% year over year and sequentially, while the company posted another GAAP net loss of around $3.5 million (–$0.08 per share).
Shares of SailPoint, Inc. (SAIL) are tumbling approximately 12% in premarket trading on March 18, 2026, after the company released its fiscal fourth-quarter and full-year 2026 results before the market opened. While Q4 revenue came in slightly above consensus at $295 million (+23% year-over-year), investors were rattled by disappointing forward guidance for fiscal 2027.
Shares of KC surged approximately +17% in premarket trading on March 18, 2026, from a prior close of $13.12 to approximately $15.35. The primary catalyst is Kingsoft Cloud's release of its unaudited Q4 and full-year 2025 financial results before the U.S. market open, which appear to have significantly exceeded analyst expectations.
AngloGold Ashanti (AU) shares tumbled approximately 7% in premarket trading on March 18, 2026, extending a multi-week downtrend that has erased nearly 20% of the stock's value since late January highs. The primary catalyst driving the decline is persistent investor concern over AngloGold's lowered 2026 production guidance, with the company projecting gold output of 2.80–3.17 million ounces — a roughly 3% decline from its 2025 production of 3.1 million ounces.